COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,283 Articles (22,759 medRxiv, 8,524 bioRxiv)

Most recent first Previous |  Page 340: Articles 3391-3400  | Next

Coronavirus and Post-COVID-19 Syndrome: A Systematic Review
Albalushi, S., Zarif, A., Karaduman, S., Talpeka, A., Tran, K.
10.1101/2023.09.24.23296022 — Posted: 2023-09-25
Association of Cognitive Deficits with Sociodemographic Characteristics among Adults with Post-COVID Conditions: Findings from the United States Household Pulse Survey
Wu, D. J., Liu, N.
10.1101/2023.09.22.23295981 — Posted: 2023-09-25
On some general characteristics of the spread of the COVID epidemic
Mairanowski, F., Below, D.
10.1101/2023.09.22.23295959 — Posted: 2023-09-25
Antigenicity and receptor affinity of SARS-CoV-2 BA.2.86 spike
Wang, Q., Guo, Y., Liu, L., Schwanz, L. T., Li, Z., Ho, J., Zhang, R. M., Iketani, S., Yu, J., Huang, Y., Qu, Y., Valdez, R., Lauring, A. S., Gordon, A., Wang, H. H., Liu, L., Ho, D. D.
10.1101/2023.09.24.559214 — Posted: 2023-09-25
A comprehensive study of SARS-CoV-2 main protease (Mpro) inhibitor-resistant mutants selected in a VSV-based system
Costacurta, F., Dodaro, A., Bante, D., Schoeppe, H., Sprenger, B., Moghadasi, S. A., Fleischmann, J., Pavan, M., Bassani, D., Menin, S., Rauch, S., Krismer, L., Sauerwein, A., Heberle, A., Rabensteiner, T., Ho, J., Harris, R. S., Stefan, E., Schneider, R., Kaserer, T., Moro, S., von Laer, D., Heilmann, E.
10.1101/2023.09.22.558628 — Posted: 2023-09-25
Immune Correlates of Hyperglycemia and Vaccination in a Non-human Primate Model of Long-COVID
Palmer, C. S., Perdios, C., Abdel-Mohsen, M., Mudd, J., Datta, P., Maness, N., Lehmicke, G., Golden, N., Hellmer, L., Coyne, C., Moore Green, K., Midkiff, C., Williams, K., Tiburcio, R., Fahlberg, M., Boykin, K., Kenway, C., Russell-Lodrigue, K., Bohm, R., Blair, R. V., Dufour, J., Fischer, T., Saied, A., Rappaport, J.
10.1101/2023.09.22.559019 — Posted: 2023-09-25
Multi-modal profiling of biostabilized human skin modules reveals a coordinated ecosystem response to injected mRNA-1273 COVID-19 vaccine.
Scholaert, M., Peries, M., Braun, E., Martin, J., Serhan, N., Loste, A., Bruner, A., Basso, L., Chaput, B., Merle, E., Descargues, P., Pages, E., Gaudenzio, N.
10.1101/2023.09.22.558940 — Posted: 2023-09-25
Survey of white-footed mice in Connecticut, USA reveals low SARS-CoV-2 seroprevalence and infection with divergent betacoronaviruses
Earnest, R., Hahn, A. M., Feriancek, N. M., Brandt, M., Filler, R. B., Zhao, Z., Breban, M. I., Vogels, C. B. F., Chen, N. F. G., Koch, R. T., Porzucek, A. J., Sodeinde, A., Garbiel, A., Keanna, C., Litwak, H., Stuber, H. R., Cantoni, J. L., Pitzer, V. E., Olarte Castillo, X. A., Goodman, L. B., Wilen, C. B., Linske, M. A., Williams, S. C., Grubaugh, N. D.
10.1101/2023.09.22.559030 — Posted: 2023-09-25
Positive selection underlies repeated knockout of ORF8 in SARS-CoV-2 evolution
Wagner, C., Kistler, K. E., Perchetti, G. A., Baker, N., Frisbie, L. A., Torres, L. M., Aragona, F., Yun, C., Figgins, M., Greninger, A. L., Cox, A., Oltean, H. N., Roychoudhury, P., Bedford, T. D.
10.1101/2023.09.21.23295927 — Posted: 2023-09-23
Impact of bivalent BA.4/5 BNT162b2 COVID-19 vaccine on acute symptoms, quality of life, work productivity and activity levels among symptomatic US adults testing positive for SARS-CoV-2 at a national retail pharmacy
Di Fusco, M., Sun, X., Anatale-Tardiff, L., Yehoshua, A., Coetzer, H., Alvarez, M. B., Allen, K. E., Porter, T. M., Puzniak, L., Lopez, S. M. C., Cappelleri, J. C.
10.1101/2023.09.21.23295904 — Posted: 2023-09-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).